申请人:Cumming John
公开号:US20100152197A1
公开(公告)日:2010-06-17
The present invention relates to compounds of formula (I)
The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain.
本发明涉及公式(I)的化合物。这些化合物通过拮抗CCR2b受体发挥作用,可用于治疗炎症性疾病和/或神经病理性疼痛。